Clinical Trial Update: A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of BTT1023 in patients with primary sclerosing cholangitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• BTT1023

Snippet

Sponsor: University of Birmingham | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: COMPLETED